InsiderTradr

Genomic Valley Biotech Limited (GVBL.BO)

BSE · INR · Healthcare · Biotechnology

₹41.56 (+4.98%) as of

Key statistics

Market cap
126.95M
P/E (TTM)
692.67
EPS (TTM)
0.06
Dividend yield
0.00%
52-week range
20.10 – 41.56
Beta
-0.16
Revenue (TTM)
2.15M
Profit margin
9.40%
Volume
1.61k

About Genomic Valley Biotech Limited

Genomic Valley Biotech Limited operates in horticulture business activities in India. The company involved in the commercial greenhouse/poly house cultivation of crops; commercial horticulture activities with aloe vera, tomato, bitter gourd, bottle gourd, brinjal, broccoli, cabbage, capsicum, carrot, cauliflower, cucumber, green chilies, onion, radish, ridge/sponge gourd, leafy vegetables, pumpkin, banana, guava, papaya, and strawberry; and commercial floriculture of flowers. It also undertakes contracts for its clients for erecting greenhouses; and provides turnkey consultancy services. In addition, the company manufactures and markets bio-fertilizers; and offers farmer support apps. Further, it is involved in the operation of plant tissue culture process laboratory to produce tissue cultured plantlets. The company was incorporated in 1994 and is based in Delhi, India.

Sector
Healthcare
Industry
Biotechnology
Headquarters
Delhi, India

genomicvalley.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks